MENU
GRFS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Grifols SA (GRFS) Ownership - Who owns Grifols SA?

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins... Show more

Profile

Industry
Pharmaceuticals Major
Address
Avinguda de la Generalitat, 152
Phone
+34 935712200
Employees
23744
Web
https://www.grifols.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
8.92B
P/E Ratio
20.80
Total Cash
N/A
Projected Growth
0.19
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
0.02
Total Cash/Share
N/A
Total Debt/Equity
172.98
Revenue/Share
13.27 USD as % of share price

Fundamentals

GRFS
Capitalization
8.92B
P/E Ratio
20.80
Risk (Beta)
N/A
Dividend Yield
0.02
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
172.98
Projected Growth (PEG Ratio)
0.19
Revenue/Share (as % of the share price)
13.27%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
1.20
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
2.64
Current Revenue Per Employee
79459.29
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
39.33
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
681M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
1
Gain YTD
49.272
View a ticker or compare two or three
GRFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GRFS showed earnings on July 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of plasma-derived biological medicines

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Avinguda de la Generalitat, 152
Phone
+34 935712200
Employees
23744
Web
https://www.grifols.com